Literature DB >> 15588913

Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay.

R J Dearman1, R A Skinner, N Deakin, D Shaw, I Kimber.   

Abstract

The evaluation of allergenic potential is a key parameter in the safety assessment of novel proteins, including those expressed in genetically modified crops and foodstuffs. The majority of allergic reactions to food proteins are immediate type hypersensitivity reactions in which the principal biological effector is IgE antibody; the accurate measurement of specific IgE antibody is therefore a critical factor in experimental systems designed to characterize protein allergenic potential. Due to the presence of much higher concentrations of other immunoglobulin isotypes, the assessment of specific serum IgE antibody poses substantial technical challenges. We have examined the utility of the rat basophilic leukemia (RBL) cell line for the measurement of murine IgE responses. RBL cells were sensitized with mouse monoclonal anti-dinitrophenyl (DNP) IgE antibody and challenged with DNP-albumin conjugates with various hapten substitution ratios (SR). Polyclonal anti-OVA IgE antisera were also assessed for activity in the RBL assay. Results were compared with titers measured in homologous passive cutaneous anaphylaxis (PCA) assay. Marked degranulation of RBL cells was induced by conjugates with SRs of between 16 and 32, whereas conjugates with lower SRs (of 10 or 3) failed to elicit significant serotonin release. All conjugates were able to induce mast cell degranulation in vivo in a PCA assay. Anti-OVA antisera with PCA titers of 1/32 to 1/64 failed to stimulate RBL cell degranulation, whereas high titer antibody (1/2048 to 1/4096 by PCA) induced a positive RBL cell response. Successful stimulation of RBL cell degranulation requires not only appropriate epitope densities but also high affinity antibody. These data indicate that this assay is inappropriate for the routine analysis of specific polyclonal IgE antibody responses such as those that are induced by exposure to complex protein allergens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15588913     DOI: 10.1016/j.tox.2004.08.007

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

1.  RBL-2H3 cells are an imprecise model for mast cell mediator release.

Authors:  Egle Passante; Carsten Ehrhardt; Helen Sheridan; Neil Frankish
Journal:  Inflamm Res       Date:  2009-03-20       Impact factor: 4.575

Review 2.  The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell.

Authors:  Egle Passante; Neil Frankish
Journal:  Inflamm Res       Date:  2009-08-09       Impact factor: 4.575

3.  Nanofiber-coated drug eluting stent for the stabilization of mast cells.

Authors:  Byeongtaek Oh; Chi H Lee
Journal:  Pharm Res       Date:  2014-03-25       Impact factor: 4.200

4.  Therapeutic effects of s-petasin on disease models of asthma and peritonitis.

Authors:  Kyoung-Pil Lee; Saeromi Kang; Min-Soo Noh; Soo-Jin Park; Jung-Min Kim; Hae Young Chung; Nam Kyung Je; Young-Geun Lee; Young-Whan Choi; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2015-01-01       Impact factor: 4.634

5.  Inhibitory Effects of AF-343, a Mixture of Cassia tora L., Ulmus pumila L., and Taraxacum officinale, on Compound 48/80-Mediated Allergic Responses in RBL-2H3 Cells.

Authors:  Eun Kyeong Lee; Jeongah Song; Youjin Seo; Eun Mi Koh; Seon-Hee Kim; Kyung Jin Jung
Journal:  Molecules       Date:  2020-05-22       Impact factor: 4.411

6.  Antiallergic Phorbol Ester from the Seeds of Aquilaria malaccensis.

Authors:  Michal Korinek; Vitthal D Wagh; I-Wen Lo; Yu-Ming Hsu; Hsue-Yin Hsu; Tsong-Long Hwang; Yang-Chang Wu; Yuan-Bin Cheng; Bing-Hung Chen; Fang-Rong Chang
Journal:  Int J Mol Sci       Date:  2016-03-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.